Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 22;10(5):485.
doi: 10.3390/antibiotics10050485.

Antimicrobial Resistance Patterns and Dynamics of Extended-Spectrum β-Lactamase-Producing Uropathogenic Escherichia coli in Cusco, Peru

Steev Loyola  1 , Fátima Concha-Velasco  2 , Jimena Pino-Dueñas  2 , Nancy Vasquez-Luna  2 , Paola Juarez  1 , Carlos Llanos  1 , Guillermo Salvatierra  3 , Jesus Tamariz  1 , Andres G Lescano  4
Affiliations

Antimicrobial Resistance Patterns and Dynamics of Extended-Spectrum β-Lactamase-Producing Uropathogenic Escherichia coli in Cusco, Peru

Steev Loyola et al. Antibiotics (Basel). .

Abstract

Urinary tract infections (UTIs) are a common human infection. Antibiotic resistance in extended-spectrum β-lactamase (ESBL)-producing uropathogenic E. coli (UPEC) is a major therapeutic challenge due to limited treatment alternatives. The aim was to characterize the antimicrobial resistance (AMR) and dynamics of ESBL-producing UPEC isolates from UTI cases seen at a local hospital in Cusco, Peru. Ninety-nine isolates from respective patients were characterized against 18 different antibiotics. Latent class analysis (LCA) was used to evaluate the dynamics across the study time according to resistance patterns. The median age of patients was 51 years old, and nearly half were women. ESBL-producing UPEC isolates were slightly more frequent in outpatient services than emergency rooms, and there were higher resistance rates in males compared to females. Half of the ESBL producers were resistant to aminoglycosides and nitrofurantoin. Cefoxitin and fosfomycin resistance was 29.3% and 14.1%, respectively. Resistance to carbapenems was not observed. All isolates were multidrug-resistant bacteria, and 16.2% (16/99) were also classified as extensively drug-resistant bacteria. The resistance patterns varied across the study time and differed regarding sex and healthcare service. The study revealed high levels of AMR to commonly used antimicrobials and a dynamic circulation of ESBL-producing UPEC isolates with varying resistance patterns.

Keywords: Escherichia coli; extended-spectrum β-lactamase; urinary tract infections; β-lactam resistance; β-lactamases.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Stamm W.E., Norrby S.R. Urinary Tract Infections: Disease Panorama and Challenges. J. Infect. Dis. 2001;183:S1–S4. doi: 10.1086/318850. - DOI - PubMed
    1. Foxman B. Urinary Tract Infection Syndromes: Occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. N. Am. 2014;28:1–13. doi: 10.1016/j.idc.2013.09.003. - DOI - PubMed
    1. Flores-Mireles A.L., Walker J.N., Caparon M., Hultgren S.J. Urinary tract infections: Epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol. 2015;13:269–284. doi: 10.1038/nrmicro3432. - DOI - PMC - PubMed
    1. Astete S., Madrid L., Fukuda F., Buckley A., Meritens D., Menchola J.V. Sensibilidad Antibiótica de Los Gérmenes Causantes de Infecciones Urinarias en Pacientes Ambulatorios en El Hospital Nacional Arzobispo Loayza. [(accessed on 20 September 2020)];2004 Available online: http://www.scielo.org.pe/pdf/rspmi/v17n1/a02v17n1.
    1. Hooton T.M. Clinical Practice. Uncomplicated Urinary Tract Infection. N. Engl. J. Med. 2012;366:1028–1037. doi: 10.1056/NEJMcp1104429. - DOI - PubMed